PMC6815700

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10